A fast and validated LC-MS/MS method to quantify lenvatinib in dried blood spot-Reference-Cited by-同舟云学术

A fast and validated LC-MS/MS method to quantify lenvatinib in dried blood spot

Published:2023-03 Issue: Volume:226 Page:115255
ISSN:0731-7085
Container-title:Journal of Pharmaceutical and Biomedical Analysis
language:en
Short-container-title:Journal of Pharmaceutical and Biomedical Analysis

Author:

Zanchetta Martina,Posocco Bianca^ORCID,Gagno Sara,Poetto Ariana Soledad,Orleni Marco,Canil Giovanni,Guardascione Michela,Puglisi Fabio,Toffoli Giuseppe

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry

Reference32 articles.

1. Barriers and opportunities for the clinical implementation of therapeutic drug monitoring in oncology;Menz;Br. J. Clin. Pharmacol.,2021

2. Therapeutic drug monitoring by dried blood spot: progress to date and future directions;Wilhelm;Clin. Pharmacokinet.,2014

3. Dried blood spot technique applied in therapeutic drug monitoring of anticancer drugs: a review on conversion methods to correlate plasma and dried blood spot concentrations;Iacuzzi;Pharm. Res.,2021

4. Dried blood spots analysis with mass spectrometry: Potentials and pitfalls in therapeutic drug monitoring;Antunes;Clin. Biochem.,2016

5. Strategies in quantitative LC-MS/MS analysis of unstable small molecules in biological matrices;Li;Biomed. Chromatogr.,2011

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted and untargeted metabolomics and lipidomics in dried blood microsampling: Recent applications and perspectives;Analytical Science Advances;2024-06

2. A liquid chromatography-miniature mass spectrometry (LC-Mini MS) method for quantitative analysis of risperidone and 9-hydroxyrisperidone in plasma;The Analyst;2023